The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines.

Abstract Sigma (σ) receptors have been implicated in cancer. However, to date there is little molecular data demonstrating the role of σ1 receptors in cancer. Expression of σ1 receptors in various human cancer cell lines in comparison to non-cancerous cell lines was investigated, using real time RT-PCR and by western blotting with a σ1 receptor specific antibody. Our results indicate that cancer cells express higher levels of σ1 receptors than corresponding non-cancerous cells. Localization of the σ1 receptor was investigated in MDA-MB-231 cells by immunocytochemistry and confocal microscopy, expression was visualized predominantly at the cell periphery. We have tested the effect of σ1 and σ2 drugs and a σ1 receptor silencing construct on various aspects of the metastatic process on two breast cell lines of different metastatic potential and a normal breast cell line. Both σ1 and σ2 drugs and the σ1 receptor silencing construct had effects on proliferation and adhesion for breast cancer cell lines, compared to a non-cancerous breast cell line. This data suggests σ1 receptor plays a role in proliferation and adhesion of breast cancer cells. Therefore, it is likely to be a potential target for the diagnosis and therapy of breast cancer.

[1]  E. Aydar,et al.  Sigma Receptors and Cancer , 2004, Cancer Research.

[2]  G. Hortobagyi,et al.  Expression of sigma 1 receptor in human breast cancer , 2004, Breast Cancer Research and Treatment.

[3]  W. Bowen,et al.  Sigma receptors are expressed in human non-small cell lung carcinoma. , 1995, Life sciences.

[4]  S. Wyrick,et al.  Putative σ3 sites in mammalian brain have histamine H1 receptor properties: evidence from ligand binding and distribution studies with the novel H1 radioligand [ 3 H ]-(−)-trans-1-phenyl-3-aminotetralin , 1999, Brain Research.

[5]  W. Bowen,et al.  Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. , 1994, Journal of medicinal chemistry.

[6]  P. Flamen,et al.  Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer. , 1997, Anticancer research.

[7]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[8]  G. Ponzio,et al.  Inhibition of Tumor Cell Proliferation by σ Ligands Is Associated with K+ Channel Inhibition and p27kip1 Accumulation , 2004, Journal of Pharmacology and Experimental Therapeutics.

[9]  V. Ganapathy,et al.  Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). , 1996, Biochemical and biophysical research communications.

[10]  K. Dutschka,et al.  In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA). , 1999, Nuclear medicine and biology.

[11]  W. Bowen,et al.  σ2 Receptors regulate changes in sphingolipid levels in breast tumor cells , 2002 .

[12]  W R Martin,et al.  Pharmacology of opioids. , 1983, Pharmacological reviews.

[13]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Maria E. Mycielska,et al.  Single cell adhesion measuring apparatus (SCAMA): application to cancer cell lines of different metastatic potential and voltage-gated Na+ channel expression , 2008, European Biophysics Journal.

[15]  T. Moody,et al.  Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation. , 1998, Life sciences.

[16]  A. Bossuyt,et al.  Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  P. Casellas,et al.  Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors , 2000, British Journal of Cancer.

[18]  R. Berridge,et al.  Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. lateral motility , 2003, Journal of cellular physiology.

[19]  M. E. Gulden,et al.  Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors. , 1998, Nuclear medicine and biology.

[20]  W. Bowen,et al.  Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. , 2004, European journal of pharmacology.

[21]  Teruo Hayashi,et al.  σ‐1 Receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: Potential relation to lipid raft reconstitution , 2004, Synapse.

[22]  W. Bowen,et al.  Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. , 2002, Cancer research.

[23]  Meyer B. Jackson,et al.  The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit , 2002, Neuron.